- Report
- June 2025
- 71 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 168 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 196 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 297 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 528 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 278 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 259 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- September 2024
- 144 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 141 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- June 2025
- 88 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2024
- 173 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- December 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- August 2024
- 157 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- August 2024
- 169 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- May 2025
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2025
- 183 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- November 2024
- 183 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP

Contract Manufacturing Organizations (CMOs) are companies that provide manufacturing services to the pharmaceutical industry. CMOs specialize in the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). They provide a range of services, from process development and scale-up to commercial manufacturing and packaging. CMOs are an important part of the pharmaceutical supply chain, as they enable drug companies to outsource production and focus on their core competencies.
CMOs are subject to stringent regulatory requirements, and must adhere to Good Manufacturing Practices (GMPs) to ensure the quality and safety of their products. They must also comply with the regulations of the countries in which they operate.
CMOs offer a range of advantages to drug companies, including cost savings, access to specialized expertise, and flexibility in production. They also provide a way for drug companies to quickly scale up production to meet demand.
Some of the leading CMOs in the pharmaceutical manufacturing market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more